Ten years sounds like forever, until it suddenly doesn’t. A decade-long lens helps you ignore noise and focus on what drives wealth: steady demand, pricing power, and leaders who reinvest cash wisely. It also forces patience, which most investors lack. You can live through a recession, a rate cycle, and some nasty surprises in 10 years, but only if you own businesses that keep improving while you wait. So let’s look at some Canadian stocks doing just that.
CP
Canadian Pacific Kansas City (TSX:CP) looks relevant now as trade routes across North America keep shifting, and rail still moves heavy freight cheaply. CP runs a network that connects Canada, the U.S., and Mexico, which gives it a rare one-company corridor for cross-border shipments. The Canadian stock hasn’t felt stable lately, with shares down about 15% in the last year. A pullback like that can shake out traders, even when the network keeps gaining density and efficiency.
Recent results show progress on execution. In Q3 2025, CP delivered total revenues of $3.7 billion and grew diluted earnings per share (EPS) to $1.01, while core adjusted diluted EPS reached $1.10. It also improved efficiency, with a core adjusted operating ratio of 60.7%. Right now, it trades at about 21.4 times earnings, and 19 times forward earnings. If Mexico-to-U.S. manufacturing lanes keep expanding, CP can benefit, but freight recessions, labour disputes, and border friction, or weaker industrial demand can cut pricing power.
CSU
Constellation Software (TSX:CSU) matters now as it often thrives when markets feel messy. CSU buys niche, mission-critical software businesses, then lets each one run with a long-term, decentralized playbook. The Canadian stock has taken a bruising recently since its long-time CEO and founder Mark Leonard stepped down. Today, the Canadian stock is down about 22% year to date, and 44% in the last year.That kind of drawdown feels awful in the moment, yet it can create opportunity if fundamentals keep compounding and management keeps its discipline.
The fundamentals still look lively. In Q3 2025, CSU grew revenue 16% year over year to $3 billion and increased net income attributable to common shareholders to $210 million, or $9.89 per diluted share. It also reported free cash flow available to shareholders of $529 million, up 46% from a year earlier. Today it trades at about 58 times earnings, and 17 times forward earnings. That gap hints at earnings growth ahead, but CSU can stumble if it overpays for acquisitions or if deal competition heats up. Yet today’s investors can grab a solid deal if the Canadian stock recovers.
BEP
Brookfield Renewable Partners (TSX:BEP.UN) looks timely as power demand keeps climbing and electrification keeps spreading into transport and data centres. BEP.UN owns and operates renewable assets, with hydro as a key anchor, and it develops new projects as well. The unit price has swung with interest rates, but at writing, shares are already up 5% year-to-date, and 27% in the last year. When rates move fast, this Canadian stock can feel like a yo-yo, so you need a long horizon and a clear thesis.
The cash picture remains the real story. In Q3 2025, Brookfield Renewable reported funds from operations (FFO) of $302 million, or $0.46 per unit, up 10% year over year. Accounting earnings can swing, so investors often lean on FFO and distributions instead. Fund data shows an annual dividend around $2.04 per unit, about a 5.2% yield, which helps while you wait. Future upside can come from project completions and better financing terms, while drought, permitting delays, and debt costs can bite.
Bottom line
If you want a 2036-friendly mix, these three Canadian stocks cover a lot of ground without forcing you to chase the next shiny thing. CP can compound through route density and relentless efficiency. CSU can keep buying small software cash engines and turning them into bigger ones. BEP.UN can ride the long runway for clean power and grid upgrades while paying you to wait. None of this guarantees wins, and you should expect uncomfortable stretches, but patient owners often earn the payoff.
